celecoxib has been researched along with n-(3-(aminomethyl)benzyl)acetamidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamilton, LC; Warner, TD | 1 |
| Anichini, A; Bersani, I; Molla, A; Piris, A; Scarito, A; Vegetti, C; Zanon, M | 1 |
2 other study(ies) available for celecoxib and n-(3-(aminomethyl)benzyl)acetamidine
| Article | Year |
|---|---|
Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib.
Topics: 6-Ketoprostaglandin F1 alpha; Amidines; Analysis of Variance; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylamines; Celecoxib; Crotonates; Cyclooxygenase 2; Dexamethasone; Diclofenac; Enzyme Inhibitors; Hydroxybutyrates; Isoenzymes; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitriles; Nitrites; Nitrogen Dioxide; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Toluidines | 1998 |
Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
Topics: Amidines; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Benzylamines; Camptothecin; Caspase 9; Caspase Inhibitors; Caspases; Celecoxib; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; Immunohistochemistry; Melanoma; Protein Biosynthesis; Proteins; Pyrazoles; RNA, Messenger; Sulfonamides | 2004 |